LEMTRADA vs MAVENCLAD

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Possible drug interaction. LEMTRADA and MAVENCLAD are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LEMTRADA	MAVENCLAD
Rating	70/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ALEMTUZUMAB	CLADRIBINE
Manufacturer	Genzyme	Emd Serono
Dosage forms	Injectable	Tablet
Drug class	Cd52-Directed Cytolytic Antibody	Purine Antimetabolite
Boxed warning	Boxed warning	Boxed warning
Treats	B-Cell Chronic Lymphocytic Leukemia	Hairy Cell Leukemia, Non-Hodgkin Lymphoma, Multiple Sclerosis

lemtrada mavenclad

Rating

70/100

Pharmacy pays

—

Type

Active ingredient

ALEMTUZUMAB

CLADRIBINE

Manufacturer

Genzyme

Emd Serono

Dosage forms

Injectable

Tablet

Drug class

Cd52-Directed Cytolytic Antibody

Purine Antimetabolite

Boxed warning

Treats

B-Cell Chronic Lymphocytic Leukemia

Hairy Cell Leukemia, Non-Hodgkin Lymphoma, Multiple Sclerosis

Frequently asked questions

Which is better-rated, Lemtrada or Mavenclad?

Lemtrada and Mavenclad are tied at 3.5 out of 5 by our independent rating.

What is the difference between Lemtrada and Mavenclad?

Lemtrada contains Alemtuzumab, while Mavenclad contains Cladribine — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.